(Q33641201)

28 July 2017

title

FISH+CD34+CD38- cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome (English)

1 reference

28 July 2017

1 reference

acute myeloid leukemia

1 reference

Libing Wang

1

1 reference

28 July 2017

Lei Gao

2

1 reference

28 July 2017

Sheng Xu

3

1 reference

28 July 2017

Shenglan Gong

4

1 reference

28 July 2017

Li Chen

5

1 reference

28 July 2017

Shuqing Lü

6

1 reference

28 July 2017

Jie Chen

7

1 reference

28 July 2017

Huiying Qiu

8

1 reference

28 July 2017

Xiaoqian Xu

9

1 reference

28 July 2017

Xiong Ni

10

1 reference

28 July 2017

Xianmin Song

11

1 reference

28 July 2017

Weiping Zhang

12

1 reference

28 July 2017

Jianmin Yang

13

1 reference

28 July 2017

Min Liu

14

1 reference

28 July 2017

Xiaoxia Hu

15

1 reference

28 July 2017

Jianmin Wang

16

1 reference

28 July 2017

publication date

7 November 2013

1 reference

Journal of Hematology & Oncology

28 July 2017

published in

1 reference

28 July 2017

volume

6

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

85

1 reference

Creative Commons Attribution 2.0 Generic

28 July 2017

copyright license

start time

7 November 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1756-8722-6-85

0 references

cites work

Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028871

Image cytometry-based detection of aneuploidy by fluorescence in situ hybridization in suspension

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028871

Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028871

Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028871

A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028871

High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028871

Current findings for recurring mutations in acute myeloid leukemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028871

Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028871

High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028871

Anthracycline dose intensification in acute myeloid leukemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028871

The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028871

High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028871

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028871

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028871

Stem cell gene expression programs influence clinical outcome in human leukemia.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-6-85

Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-6-85

Non-parametric inference for cumulative incidence functions in competing risks studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-6-85

Impact of molecular prognostic factors in cytogenetically normal acute myeloid leukemia at diagnosis and relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-6-85

Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial

21 January 2018

1 reference

12 December 2020

Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup

1 reference

12 December 2020

Censoring distributions as a measure of follow-up in survival analysis

1 reference

12 December 2020

Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission

1 reference

12 December 2020

Identifiers

DOI

10.1186/1756-8722-6-85

1 reference

Dimensions Publication ID

28 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1756-8722-6-85

9 September 2019

1 reference

28 July 2017

1 reference